Cilostazol Tablet
Product Images NDC 71610-822

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Cilostazol (NDC 71610-822). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (71610 0822 26)

This text is not available.*

FDA Label Image

Aphena (Aphena)

FDA Label Image

Figure1 (Figure1)

FDA Label Image

Figure2 (Figure2)

Percent Mean Improvement in Maximal Walking Distance for different groups, including Placebo, Cilostazol 50 mg twice a day, and Cilostazol 100 mg twice a day, measured over different durations such as 19 weeks and 24 weeks.*

FDA Label Image

Structure (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.